Aug. 10, 2020 Price forecast | 2 weeks: -1.56% | 1 month: -7.04% | 3 months: -7.59%


CBIO stock forecast

Our latest prediction for Catalyst Biosciences, Inc.'s stock price was made on the Aug. 10, 2020 when the stock price was at 5.66$.

In the short term (2weeks), CBIO's stock price should underperform the market by -1.56%. During that period the price should oscillate between -10.25% and +13.21%.

In the medium term (3months), CBIO's stock price should underperform the market by -7.59%. During that period the price should oscillate between -40.49% and +29.82%.

Create a solid portfolio with CBIO

Add CBIO to your portfolio and optimize it!


About Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.

At the moment the company generates 18M USD in revenues.

On its last earning announcement, the company reported a loss of -3.50$ per share.

The book value per share is 11.47$

Catalyst Biosciences, Inc. website


Three months stock forecastAug. 10, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
18M 100.00% -50M -275.30% -48M -3.50 - - 14M 11.47 -37M - -37M